Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Obstetrics and Gynecology
|
December 23, 2009
Paracervical block efficacy in office hysteroscopic sterilization: a randomized controlled trial
Scott Chudnoff, Mark Einstein, Mark Levie
Gynecologic Oncology
|
December 14, 2004
Recurrent small cell lung cancer presenting as bilateral adnexal masses
Paniti Sukumvanich, Mark Einstein, Brian Wagner, et al.
Obstetrics and Gynecology
|
August 24, 2013
In reply
L Stewart Massad, Mark Einstein, Warner Huh, et al.
Gynecologic Oncology
|
May 5, 2009
The impact of human papillomavirus vaccination on cervical cancer prevention efforts
L Stewart Massad, Mark Einstein, Evan Myers, et al.
Current Medical Research and Opinion
|
May 21, 2021
Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States
Vimalanand Prabhu, Niranjan Kathe, Kunal Saxena, et al.
Journal of Gynecologic Oncology
|
April 16, 2015
Physical activity for an ethnically diverse sample of endometrial cancer survivors: a needs assessment and pilot intervention
Amerigo Rossi, Alyson Moadel-Robblee, Carol Ewing Garber, et al.
Journal of Lower Genital Tract Disease
|
April 4, 2020
The Effect of Forced Cough to Minimize Pain and Discomfort at the Time of Colposcopy-Guided Cervical Biopsy
Theresa Kuhn, Adanna Ukazu, Pamela Ohman Strickland, et al.
International Journal of Cancer
|
December 23, 2016
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice
Nicolas Wentzensen, Marc Arbyn, Johannes Berkhof, et al.
Gynecologic Oncology
|
July 24, 2013
Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010
June Y Hou, Santiago Aparo, Mohammad Ghalib, et al.
Investigational New Drugs
|
May 10, 2006
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancers
Sanjay Goel, Kavita Desai, Manuel Macapinlac, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Obstetrics and Gynecology
|
December 23, 2009
Paracervical block efficacy in office hysteroscopic sterilization: a randomized controlled trial
Scott Chudnoff, Mark Einstein, Mark Levie
Gynecologic Oncology
|
December 14, 2004
Recurrent small cell lung cancer presenting as bilateral adnexal masses
Paniti Sukumvanich, Mark Einstein, Brian Wagner, et al.
Obstetrics and Gynecology
|
August 24, 2013
In reply
L Stewart Massad, Mark Einstein, Warner Huh, et al.
Gynecologic Oncology
|
May 5, 2009
The impact of human papillomavirus vaccination on cervical cancer prevention efforts
L Stewart Massad, Mark Einstein, Evan Myers, et al.
Current Medical Research and Opinion
|
May 21, 2021
Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States
Vimalanand Prabhu, Niranjan Kathe, Kunal Saxena, et al.
Journal of Gynecologic Oncology
|
April 16, 2015
Physical activity for an ethnically diverse sample of endometrial cancer survivors: a needs assessment and pilot intervention
Amerigo Rossi, Alyson Moadel-Robblee, Carol Ewing Garber, et al.
Journal of Lower Genital Tract Disease
|
April 4, 2020
The Effect of Forced Cough to Minimize Pain and Discomfort at the Time of Colposcopy-Guided Cervical Biopsy
Theresa Kuhn, Adanna Ukazu, Pamela Ohman Strickland, et al.
International Journal of Cancer
|
December 23, 2016
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice
Nicolas Wentzensen, Marc Arbyn, Johannes Berkhof, et al.
Gynecologic Oncology
|
July 24, 2013
Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010
June Y Hou, Santiago Aparo, Mohammad Ghalib, et al.
Investigational New Drugs
|
May 10, 2006
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancers
Sanjay Goel, Kavita Desai, Manuel Macapinlac, et al.
Page
of 2